Abstract
Barrett’s esophagus (BE) is a well-recognized risk factor for esophageal adenocarcinoma (EAC). Endoscopic eradication prevents development of EAC. Presently, radiofrequency ablation (RFA) is the most common eradication therapy. While recent studies have suggested that balloon cryotherapy is non-inferior to RFA in the management of dysplastic BE, limited data exists regarding longitudinal outcomes of spray liquid nitrogen cryotherapy (SLNC) compared to RFA. This study aims to bridge a knowledge gap assessing the number of sessions needed to successfully eradicate dysplastic BE and outcomes for those who failed initial treatment modality.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
